Radiation before surgery for retroperitoneal soft-tissue sarcoma
Part of Cancer, Injuries & trauma clinical trials.
This trial tests giving a shorter, lower-dose radiation treatment before surgery for a retroperitoneal (deep belly/back space) soft-tissue sarcoma. The goal is to shrink or control the tumor and make surgery more effective and safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a primary (first) soft-tissue sarcoma in the retroperitoneal or lower pelvic area
- Your cancer did not start in bone, the stomach/abdominal organs, or gynecologic organs
- The tumor can fit safely within one radiation treatment area, without spreading into the sciatic notch or across the diaphragm
- Your biopsy confirms it is a sarcoma type the study accepts (some subtypes are excluded)
- No spread to other parts of the body, and it has not already received radiation treatment
- Your health tests are good enough for surgery and radiation (kidney, liver, and bone marrow function, and good activity level)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach for people with a rare type of cancer called retroperitoneal sarcoma, which grows in the back of the belly. It combines a short course of radiation and an immunotherapy drug before surgery, aiming to shrink the tumor and improve the chances of successful removal.
This study tests whether a short course of radiation before surgery can treat retroperitoneal sarcoma (a rare cancer in the back of the belly). It is for people whose tumor is removable and who have not had previous radiation in the same area.
This trial tests a shorter course of radiation (just 5 days) before surgery for soft tissue sarcoma. The goal is to see if a brief, high-dose radiation schedule works as well as or better than the usual longer course—and may be more convenient for you.
This trial studies a shorter-course proton radiation plan given before surgery for certain soft tissue sarcomas. The goal is to treat the tumor locally while helping surgery be safer or more effective.
This study tests a 5-day course of radiation before surgery instead of the usual 5 weeks. It may help people who face challenges like travel or tumor growth that make the longer schedule difficult.
This trial studies giving radiation before surgery to help control a soft-tissue sarcoma while keeping surgery as less extensive as possible. It may help shrink the tumor and improve what the surgeon can remove.
Hear when a new Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.